Ukr.Biochem.J. 2021; Volume 93, Issue 2, Mar-Apr, pp. 107-114


Inclusion of enterosorbents in anti-inflammatory therapy improve treatment effectiveness in copd patients during exacerbations

S. V. Kucher*, O. V. Lototska

I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine;

Received: 29 January 2021; Accepted: 23 April 2021

Inflammation plays a key role in the development of chronic obstructive pulmonary disease (COPD), and manifests as increased levels of inflammation markers such as cytokines. The purpose of this study was to examine the effect of enterosorbents on IL-1β, TNF-α and IL-10 levels in COPD patients with exacerbations, while taking into account their ages. Patients were divided into two age groups: age group 1 (40-59 years) and age group 2 (>60 years). Levels of IL-1β, TNF-α and IL-10 were determined by enzyme-linked immunosorbent assay. Levels of pro-inflammatory and anti-inflammatory cytokines were increased in both age groups of COPD patients during exacerbations compared to the healthy control group. Pro-inflammatory cytokines (IL-1β, TNF-α) increased more in age group 2. Basic therapy (BT) had positive impacts. Addition to BT of the enterosorbents Enterosgel and Carboline decreased serum levels of IL-1β, TNF-α and IL-10 in both age groups more than after BT alone. Greater changes were observed in age group 2. We found that addition of the enterosorbents Carboline or Enterosgel to basic therapy of COPD patients during exacerbations decreased levels of IL-1β, TNF-α and IL-10 in patients of both age groups (40-59 years and >60 years).

Keywords: , ,


  1. Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16-27. PubMed, CrossRef
  2. Su B, Liu T, Fan H, Chen F, Ding H, Wu Z, Wang H, Hou S. Inflammatory Markers and the Risk of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. PLoS One. 2016;11(4):e0150586.  PubMed, PubMedCentral, CrossRef
  3. Perret  J, McDonald C, Apostolopoulos V. Elevated serum interleukin-5 levels in severe chronic obstructive pulmonary disease. Acta Biochim Biophys Sin (Shanghai). 2017;49(6):560-563. PubMed, CrossRef
  4. Gulati K, Guhathakurta S, Joshi J, Rai N, Ray A. Cytokines and their Role in Health and Disease: A Brief Overview. MOJ Immunol. 2016; 4(2): 00121. CrossRef
  5. Dinarello CA. Proinflammatory cytokines. Chest. 2000;118(2):503-508. PubMed, CrossRef
  6. Iyer SS, Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol. 2012;32(1):23-63. PubMed, PubMedCentral, CrossRef
  7. Fried TR, Vaz Fragoso CA, Rabow MW. Caring for the older person with chronic obstructive pulmonary disease. JAMA. 2012;308(12):1254-1263.  PubMed, PubMedCentral, CrossRef
  8. Voronina LP. Obstructive lung disease in the practice of a geriatrician. Med Novosti. 2014;(3): 17-22. (In Russian).
  9. Howell CA, Mikhalovsky SV, Markaryan EN, Khovanov AV. Investigation of the adsorption capacity of the enterosorbent Enterosgel for a range of bacterial toxins, bile acids and pharmaceutical drugs. Sci Rep. 2019;9(1):5629. PubMed, PubMedCentral, CrossRef
  10. Shevchuk OO, Posokhova EA, Sakhno LA, Nikolaev VG. Theoretical ground for adsorptive therapy of anthracyclines cardiotoxicity. Exp Oncol. 2012;34(4):314-322. PubMed
  11. Unified clinical protocol of primary, secondary (specialized), tertiary (highly specialized) medical care and medical rehabilitation “Chronic obstructive pulmonary disease” Order of the Ministry of Health of Ukraine from 27.06.2013 № 555 [Electronic resource]. Regime of access : (In Ukrainian).
  12. Nikolaev VG. Enterosgel. K.: Bogdana, 2009: 159 p. (In Russian).
  13. Practical recommendations for the use of granular carbon enterosorbents “Carboline”: methodical recommendations / Nikolaev VG, Andreychin MA, Bardakhivska KI, Sakhno LO, Kopcha VS, Yushko LO, Nikolaeva VV, Ivanyuk AA, Shevchuk OO / RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine. K.: IEPOR NASU, 2013. 16 с. (In Ukrainian).
  14. Rebrova OYu. Statistical analysis of medical data. Application of Statistica software package. M .: MediaSphere, 2006. 312 с. (In Russian).
  15. Delieva A, Dolinina L, Trofimov V. The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity. Eur Respir J. 2013; 42(Suppl 57): P600.
  16. Colarusso C, Terlizzi  M, Molino A, Pinto A, Sorrentino R. Role of the inflammasome in chronic obstructive pulmonary disease (COPD). Oncotarget. 2017;8(47):81813-81824. PubMed, PubMedCentral, CrossRef
  17.  Konorev MR. Clinical pharmacology of enterosorbents of new generation. Vestnik Farmatsii. 2013;(4(62)).79-85 (In Russian).

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.